Skip to main content
. 2021 Aug 4;24(4):655–664. doi: 10.1093/neuonc/noab188

Table 3.

Summary of Instances of DLT During Radiation and Vorinostat and Subsequent Maintenance Vorinostat that are Considered in the Analysis of Time to First DLT Event

Reporting Period DLTs Observed in at Least One Patient Number of Patients With DLT Types
Radiation Therapy and Vorinostat Grade 2 creatinine elevation 1
Grade 3 agitation; Grade 3 confusion; Grade 3 hyperglycemia 1
Grade 3 anorexia 1
Grade 3 hypertension 1
Grade 3 hyponatremia 1
Grade 3 mucositis; Grade 3 thrombocytopenia 1
Grade 3 thrombocytopenia 1
Grade 3 maculopapular rash 1
Grade 4 hyperglycemia 1
Grade 4 neutropenia; Grade 3 thrombocytopenia 1
Maintenance Vorinostat Cycles 1 and 2 Grade 2 anorexia; Grade 2 weight loss 1
Grade 2 creatinine elevation 1
Grade 3 creatinine elevation 1
Grade 3 hypermagnesemia 1a
Grade 3 thrombocytopenia 3
Grade 3 thrombocytopenia; Grade 4 neutropenia 2
Grade 4 thrombocytopenia 1
Grade 4 thrombocytopenia; Grade 3 hypermagnesemia 1
Grade 4 thrombocytopenia; Grade 4 neutropenia 1
Maintenance Vorinostat Cycles 3 and 4 Grade 3 alkaline phosphatase elevation 1
Grade 3 dehydration 1
Grade 3 thrombocytopenia 1
Grade 4 neutropenia 2
Maintenance Vorinostat Cycles 5 and 6 Grade 3 depressed level of consciousness 1
Grade 4 intracranial hemorrhage 1
Maintenance Vorinostat Cycles 7 and 8 Grade 3 weight loss; Grade 2 creatinine elevation 1
Maintenance Vorinostat Cycles 9 and 10 Grade 3 weight loss 1
Total 31

For patients experiencing more than 1 DLTs, only the first DLT and associated reporting period are included in this table.

aThis patient also developed grade 3 thromboembolism during cycle 5 and 6 reporting period.